NCT06385262 2026-03-06
TOP 2301: Neoadjuvant Chemo for NSCLC
Duke University
Phase 2 Suspended
Clinical Trials
5 trialsNCT02356991 2019-11-04
A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Suspended
NCT02470065 2016-01-22
REMNANT
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Suspended
NCT00986284 2015-12-22
Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Suspended
NCT01088620 2013-03-14
Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer
WiSP Wissenschaftlicher Service Pharma GmbH
Phase 2 Suspended